BackCitius Pharmaceuticals- Warrants(02/08/2022) Overview

Citius Pharmaceuticals- Warrants(02/08/2022) Goodwill

Citius Pharmaceuticals- Warrants(02/08/2022)'s goodwill is $9.3M.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$9.35M
0.00% YoYΔ $0.00 vs prior year quarter

Peer average / median

Loading

Citius Pharmaceuticals- Warrants(02/08/2022) Goodwill History

Loading

Citius Pharmaceuticals- Warrants(02/08/2022) vs. peers: Goodwill Comparison

Loading

Citius Pharmaceuticals- Warrants(02/08/2022) Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Citius Pharmaceuticals- Warrants(02/08/2022) (CTXRW) FAQ

As of the most recent data (March 2026), CTXRW shows a goodwill of $9.3M. That compares with $9.3M in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CTXRW's goodwill is now $9.3M (was $9.3M) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether Citius Pharmaceuticals- Warrants(02/08/2022) is outperforming or lagging.

Tracking CTXRW's goodwill over time shows whether Citius Pharmaceuticals- Warrants(02/08/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $9.3M That compares with $9.3M in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Citius Pharmaceuticals- Warrants(02/08/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $9.3M) with ownership activity and broader fundamentals.

Citius Pharmaceuticals- Warrants(02/08/2022)'s goodwill is $9.3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.